Study affirms systemic safety of anti-VEGF treatments
This retrospective study explored the safety of intravitreal anti-VEGF therapy in patients with diabetic macular edema. Source: AAO
- Posted on: Aug 23 2019
- Leave a response
This retrospective study explored the safety of intravitreal anti-VEGF therapy in patients with diabetic macular edema. Source: AAO
This study described the visual outcomes and complications 1 year after pediatric cataract surgery. Source: AAO
In this prospective trial, the authors investigated IOP changes during neurosurgical procedures with opening of the dura mater and loss of cerebrospinal fluid. Source: AAO
This study compares the prophylactic effects of a dexamethasone implant versus systemic steroids in patients with uveitis who were scheduled for cataract surgery. Source: AAO
Researchers assessed the safety and efficacy of the ranibizumab Port Delivery System (PDS) for neovascular AMD. Source: AAO
This study analyzes the clinical, histologic and molecular genetic profiles of primary orbital melanoma. Source: AAO
This week, surgeons discover a forgotten needle in the eye of a 5-year-old boy, Kala preps for a third trial of their dry eye drop and electroactive contact lenses zoom in with a double blink. Source: AAO
Researchers compared refractive outcomes of primary peripheral retinal photocoagulation versus bevacizumab with delayed PRP in infants with posterior type 1 retinopathy of prematurity. Source: AAO
Aflibercept (Eylea) will soon be available in a 2-mg sterile prefilled syringe, according to a press release by Regeneron Pharmaceuticals. Source: AAO
This study used 2 imaging methods to evaluate retinal nonperfusion after anti-VEGF treatment for diabetic macular edema. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »